Current Molecular Medicine is an interdisciplinary journal focused on providing the readership with current and comprehensive reviews on fundamental molecular mechanisms of disease pathogenesis, the development of molecular-diagnosis and/or novel approaches to rational treatment. The reviews should be of significant interest to basic researchers and clinical investigators in molecular medicine. Periodically the journal will invite guest editors to devote an issue on a basic research area that shows promise to advance our understanding of the molecular mechanism(s) of a disease or has potential for clinical applications.

Current Nanomaterials, a peer reviewed journal publishes full-length/mini reviews, original research articles and thematic issues on experimental and applied research on nanomaterials. The scope covers the synthesis, structure, properties, characterization and application of nanomaterials. The journal will cover all areas of nanomaterial science, engineering and nanotechnology with emphasis on all aspects of research on a wide range of nanomaterials including nanocomposites, inorganic materials, polymeric and biological materials and hybrid materials.
This inter-disciplinary journal will be of interest to scientists in both the physical and biomedical /pharmaceutical related disciplines in nanoscience research.
Current Nanomaterials is an international, peer-reviewed journal on all aspects of nanomaterials, published quarterly (print & online) by Bentham Science Publishers.

Current Nanoscience publishes (a) Authoritative/Mini Reviews, and (b) Original Research and Highlights written by experts covering the most recent advances in nanoscience and nanotechnology. All aspects of the field are represented including nano-structures, nano-bubbles, nano-droplets and nanofluids. Applications of nanoscience in physics, material science, chemistry, synthesis, environmental science, electronics, biomedical nanotechnology, biomedical engineering, biotechnology, medicine and pharmaceuticals are also covered. The journal is essential to all researches involved in nanoscience and its applied and fundamental areas of science, chemistry, physics, material science, engineering and medicine.
Current Nanoscience also welcomes submissions on the following topics of Nanoscience and Nanotechnology:
●     Nanoelectronics and photonics
●     Advanced Nanomaterials
●     Nanofabrication and measurement
●     Nanobiotechnology and nanomedicine
●     Nanotechnology for energy
●     Sensors and actuators
●     Computational nanoscience and technology

Current Neurovascular Research (CNR) provides a cross platform for the publication of scientifically rigorous research that addresses disease mechanisms of both neuronal and vascular origins in neuroscience. The journal serves as an international forum for the publication of novel and pioneering original work as well as timely neuroscience research reviews in the disciplines of cell developmental disorders, plasticity, and degeneration that bridge the gap between basic science research and clinical discovery. CNR emphasizes the elucidation of disease mechanisms, both cellular and molecular, which can impact the development of unique therapeutic strategies for neuronal and vascular disorders.

Current Nutrition & Food Science publishes frontier research on recent advances in food and nutrition pertaining to their nutritional value, their impact on health and disease, and their molecular and biochemical actions. The journal aims to publish high-quality original research and full-length/mini-review articles, and thematic issues in the following areas:

• Brewing
• Cereal Science
• Clinical Nutrition
• Dairy Science
• Dietetics
• Food Additives
• Food Contaminants
• Food Chemistry
• Food Biochemistry
• Food Engineering
• Food Processing
• Food Microbiology
• Food Technology
• Food Quality
• Food Safety
• Meat Science
• Nutrition and Metabolism
• Nutrition Science
• Nutritional Biochemistry
• Vitamin Research

Current Nutrition & Food Science is an international, peer-reviewed journal on all aspects of food and nutrition, published monthly (print & online) by Bentham Science Publishers. 

Current Organocatalysis is an international peer-reviewed journal that publishes significant research in all areas of organocatalysis. The journal covers organo homogeneous/heterogeneous catalysis, innovative mechanistic studies and kinetics of organocatalytic processes focusing on practical, theoretical and computational aspects. It also includes potential applications of organocatalysts in the fields of drug discovery, synthesis of novel molecules, synthetic method development, green chemistry and chemoenzymatic reactions.
This journal also accepts papers on methods, reagents, and mechanism of a synthetic process and technology pertaining to chemistry. Moreover, this journal features full-length/mini review articles within organocatalysis and synthetic chemistry. It is the premier source of organocatalysis and synthetic methods related information for chemists, biologists and engineers pursuing research in industry and academia.

Current Pediatric Reviews publishes frontier reviews/mini-reviews, clinical drug studies, and guest-edited thematic issues on all the latest advances in neonatal and pediatric medicine. The aim of the journal is to publish top quality review articles dedicated to clinical research in neonatology and pediatrics. The scope covers cardiology and respiratory systems, dentistry, dermatology, developmental behavior, gastroenterology, hematology, immunology and infectious diseases, neurology, nutrition, oncology, ophthalmology, otorhinolaryngology and psychiatry, surgery, tropical medicine, urology, nephrology, perinatal medicine, neonatology and adolescent medicine. The journal is essential reading for all researchers and clinicians in the field of neonatal and pediatric medicine.

Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics in both pre-clinical and clinical areas of Pharmaceutical Biotechnology. Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.

Current Pharmacogenomics and Personalized Medicine (CPPM) is a transdisciplinary, peer-reviewed biomedical journal that reports new findings and cutting-edge concepts in all areas of pharmacology. Special consideration is given to articles on pharmacogenomics and personalized medicine. CPPM is an accelerator for global personalized medicine and pharmacogenomics, as well as preclinical and clinical pharmacology. Importantly, the journal provides a multi-disciplinary, integrated platform from cell to society to address diagnostics and the responsible pharmacogenomics applications in developing countries and the entire range of translational science from bench to bedside in various therapeutic areas, such as oncology, neuropharmacology, and cardiovascular and endocrine diseases, amongst others.
CPPM cooperates with the Ibero-American Network of Pharmacogenetics and the Pacific Rim Association for Clinical Pharmacogenetics and welcomes peer-reviewed contributions from authors in any global region.
The journal's scope is defined by four interconnected aims. First, we are interested in genomics/postgenomics biotechnologies and diagnostics that enable global personalized medicine science (including and beyond pharmacogenomics) as long as they explain person-to-person and population differences in disease susceptibility or response to a health intervention and can be substantiated. Second, we approach personalized medicine as ‘personalized health interventions’ focusing primarily on drug therapy, but also other interventions, such as nutrition, vaccines, surgical devices, and emerging cell-based therapies that collectively contribute to healthcare. Third, we strive to integrate molecular and clinical investigation with public policy, global health diplomacy, and social studies of biotechnology, which collectively shape postgenomics future(s) and innovation trajectories in life sciences. Fourth, we are interested in all aspects of translational pharmacology, from preclinical to clinical applications in any therapeutic area that will advance the practice of medicine for the benefit of patients worldwide, including non-communicable diseases as well as infectious diseases in the post-COVID world.
Priority will be given to expert reviews/ mini-reviews and research articles that include original ideas and findings related to the scope and mandate of the journal. Unsolicited submissions are welcome.
Current Pharmacogenomics and Personalized Medicine is an international, peer-reviewed journal on all aspects of pharmacogenomics and personalized medicine published continuously (print & online) by Bentham Science Publishers.

The journal publishes original research articles, letters, case reports, reviews/mini-reviews, editorials, commentaries, perspectives, letters to the editor, and guest edited thematic issues in various topics related to physics.
It is not limited to any one aspect of a specific field but focuses on a wide range of sub-fields within that field. Articles with interdisciplinary features are especially popular. Articles in the following fields are of particular interest to the readers of this journal:
●     Astronomy and Astrophysics
●     Atmospheric Physics
●     Atomic and Molecular Physics And Optics
●     Biophysics
●     Chemical Physics
●     Electromagnetism
●     Experimental Physics
●     General Physics
●     Geophysics and Planetology
●     Instrumentation
●     Medical Physics
●     Soft Matter Physics
●     Modern Cosmology
●     Nature Physics
●     Nuclear and High Energy Physics
●     Quantum Physics
●     Radiation
●     Statistical and Nonlinear Physics
●     Surfaces and Interfaces
●     Thermal Physics